Equity · NYSE · USD

TMO

Thermo Fisher Scientific Inc

$659.04

Today

+$0.52+0.08%

vs previous close

Quote

Open: $657.04
High: $671.47
Low: $655.78
Prev close: $658.52

Sector: Healthcare
Industry: Life Sciences Tools & Services
Size: Large-cap
Market cap: $243.5B
Shares out: 371.6M
Country: US
IPO: Aug 27, 1980
Exchange: NYSE
Website: corporate.thermofisher.com
Next earnings: 2026-10-20 · Before open · EPS est. 6.47

Compare →Earnings calendar →

Price chart Pro

Loading chart…

Company briefing

What TMO is

Plain English context — why the name shows up in the news, and what to watch next. Not a tip.

In plain English

Thermo Fisher Scientific sells laboratory equipment, reagents, and services used in life sciences and diagnostics, serving researchers,…

From the wire

Recent headlines

Live company news for TMO — each headline includes a ClearTape brief in plain English; open the original for the full story.

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics DevelopmentIn brief
WALTHAM, Mass., September 23, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth and protein production across CHO-K1 cell lines.
Yahoo · Sep 23, 2026
Global Pharmaceutical Filtration Report: Biologics Manufacturing Shifts as Danaher, Merck KGaA, Sartorius, 3M and Thermo Fisher Reshape the MarketIn brief
Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems.Dublin, Sept.
Yahoo · Sep 23, 2026
Bioreactors Market Outlook 2026-2035 - Featuring Profiles of 3 Leading Companies: Sartorius, Thermo Fisher Scientific, and DanaherIn brief
Bioreactors Market Gains Momentum as Single-Use Systems, Automation and Advanced Therapies Reshape BiomanufacturingDublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.
Yahoo · Sep 23, 2026
Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and MoreIn brief
Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.The global Gene Transfer Technologies Market is projected to witness robust growth during the forecast period from 2026 to 2036, driven by the rapid…
Yahoo · Sep 23, 2026
Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market ShareIn brief
Personalized medicine and chronic disease care are driving demand for TDM, with opportunities in consumables, automation, point-of-care devices, AI software and pharmacogenomics.Dublin, Sept.
Yahoo · Sep 23, 2026
Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market ShareIn brief
Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use.Dublin, Sept.
Yahoo · Sep 23, 2026
NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)In brief
The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid whole genome and exome sequencing, next-generation sequencing, chromosomal microarrays and personalized neonatal care.
Yahoo · Sep 22, 2026
Europe Automated and Closed Cell Therapy Processing Systems Market Report (2026-2033) Featuring Profiles of Thermo Fisher Scientific, Cytiva, Sartorius, Miltenyi Biotec B.V. & Co., Lonza GroupIn brief
Europe’s cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturingDublin, Sept.
Yahoo · Sep 22, 2026

Same sector

Peers · Healthcare

Latest on this name

Insights & deeper context

1 recent card — open any for the full deeper dive.

stockTradersNeutralNear termBenzingaMRNA MRK

Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthrough

In brief

Moderna and Merck’s Phase 3 melanoma vaccine win validates mRNA oncology, sending shares soaring and boosting confidence in the platform’s future.

Open card →

Filings & reports

SEC and filing-linked cards

No filings tagged yet

Filing-linked cards for TMO will show up here when available.

Indexes like the S&P 500 are shown via liquid ETFs (e.g. SPY). Company profile and quotes use live market data when available.

TMO

In plain English

Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthrough

01In brief

In brief